Actual Medicinal Product (AMP) Donepezil 10mg tablets (Bristol Laboratories Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Original packaging may contain desiccant. Manufacturer recommends storing in original container. Anecdotal reports of use in MCAs for 14 days (low quality evidence).
- Provenance
-
This recommendation is based on the products Aricept 10mg tablets (Eisai Ltd) and donepezil 10mg tablets (Aurobindo Pharma - Milpharm Ltd.).
- Generic
- Donepezil
- Formulation
- Donepezil 10mg tablets
-
Donepezil
-
Donepezil 10mg tablets
-
Donepezil 10mg tablets (Bristol Laboratories Ltd)
-
-
Donepezil 5mg orodispersible tablets sugar free
Donepezil 10mg orodispersible tablets